A Study on the Intraject Instructions for Use

This study has been completed.

Sponsored by:	Zogenix, Inc.
Information provided by:	Zogenix, Inc.
ClinicalTrials.gov Identifier:	NCT00619554

Purpose

This study is designed to create an instruction set simple enough to be understood by migraine subjects as they were experiencing miagraine attacks.

Condition
Healthy

Study Type:	Observational
Study Design:	Prospective
Official Title:	Zogenix Intraject Instructions for Use Pilot Study

Further study details as provided by Zogenix, Inc.:

Enrollment:	19
Study Start Date:	July 2007
Primary Completion Date:	August 2007 (Final data collection date for primary outcome measure)

Eligibility

Study Population

Healthy volunteers from the community

Criteria

Inclusion Criteria:

Contacts and Locations

No Contacts or Locations Provided

More Information

Responsible Party:	Zogenix, Inc. ( Steve Farr, PhD. )
Study ID Numbers:	ZX000-0702
Study First Received:	February 7, 2008
Last Updated:	February 20, 2008
ClinicalTrials.gov Identifier:	NCT00619554
Health Authority:	United States: Institutional Review Board

Keywords provided by Zogenix, Inc.:

Healthy volunteers

Study placed in the following topic categories:

Healthy

ClinicalTrials.gov processed this record on January 16, 2009